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All researchers aim to publish their works in high-
impact journals because success in research is usually 
judged by publications within the scientific community 
[1]. On the other hand, every journal wants to recruit 
high-quality and decent papers that will be frequently 
cited in other journals [2,3]. This is a way for a journal 
to secure its reputation despite general debate and criti-
cism on the reliability of the impact factor as a measure 
of a journal [2,4]. In 2011, the Korean Society of Nephrol-
ogy, led by Dr. Yoon Sik Chang at the time, planned to 
enhance its own official journal by extending the scope of 
readership beyond its regional boundaries to the globe. 
Commencing with volume 31 in 2012, The Korean Jour-
nal of Nephrology changed its name to Kidney Research 
and Clinical Practice (KRCP) and became an internation-
al, peer-reviewed journal published in English, allowing 
scientists worldwide to submit their works to the journal. 
KRCP editors have made efforts to increase the cita-
tions of papers recently published in KRCP and enhance 
our reputation. To attain this end, high standards for 
publication in KRCP have been applied to all submitted 
manuscripts. Like other journals, some papers have been 
immediately rejected by deputy editors at our editorial 
office (desk rejection). This rapid decision is efficient 
for both authors and reviewers. Although our interest-
ing cases have often been cited by other scientists, we 
decided not to consider the manuscript category of 
case reports. Submissions from international research-
ers have gradually increased in past years, but we have 
maintained quarterly publication of high-quality articles. 
Consequently, our current rejection rate is approximately 
65%, which is higher than in previous years. 
We followed all papers submitted to KRCP from January 
2015 to December 2019. Because of our recent editorial 
policy, the numbers of rejected manuscripts increased 
(Table 1). However, such a strict selection policy may 
have been disheartening for authors, lacking specific 
criticism on the rejected manuscripts and possibly over-
looking potentially important papers [5]. Setting aside 
the evaluation results, some works charting the efforts 
of individual researchers would remain unpublished to 
their disappointment. Contrary to these concerns, our 
search through PubMed, KoreaMed and Google Scholar 
found that about 69% of articles rejected from KRCP from 
2015 to 2018 were subsequently published in other in-
ternational or domestic journals or finally in KRCP after 
resubmission (Fig. 1). Interestingly, quite a few papers 
accepted elsewhere were published in journals indexed 
in the Science Citation Index or Science Citation Index 
Expanded, operated by Clarivate Analytics. We believe 
that the comments from our reviewers were effective in 
helping the authors improve their manuscripts to sub-
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sequently be accepted by other journals, including ones 
indexed by a major abstracting and indexing service. 
Rejection from a journal does not necessarily mean that 
the work is of poor quality. Instead, it may be related to 
the paper’s scope, style or theme differing from the re-
quirements of the journal [2]. Furthermore, authors can 
turn failure into opportunity by publishing their valuable 
discoveries in other peer-reviewed journals. The editors 
and editorial board of KRCP are deeply indebted to all of 
their authors for submitting their ‘tour de force’. It goes 
without saying that the reviewers and readers of KRCP 
are also important contributors, judging the submitted 
manuscripts and spreading papers published in the jour-
nal.
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Figure 1. Destinations of articles rejected by KRCP from Janu-
ary 2015 to December 2018. 
KRCP, Kidney Research and Clinical Practice; SCI(E), Science Cita-
tion Index or Science Citation Index Expanded.
Table 1. The rejection numbers of manuscripts submitted to 








2019 27 43 70
2018 32 41 73
2017 16 14 30
2016 7 21 28
2015 9 33 42
Data are presented as the number. 
KRCP, Kidney Research and Clinical Practice.
